Big data

27 November 2019 - Massive amounts of data are generated on a daily basis that could potentially be harnessed to ...

Read more →

The challenges of sharing data in an era of politicised science

21 November 2019 - The goal of making science more transparent—sharing data, posting results on trial registries, use of preprint servers, ...

Read more →

10 year update on study results submitted to ClinicalTrials.gov

14 November 2019 - A decade after ClinicalTrials.gov launched a database for reporting results of clinical trials, the database includes results ...

Read more →

Google’s ‘Project Nightingale’ gathers personal health data on millions of Americans

11 November 2019 - Search giant is amassing health records from Ascension facilities in 21 states; patients not yet informed. ...

Read more →

In generic drug plants in China and India, data falsification is still a problem

29 October 2019 - As the generic drug industry faces allegations of data manipulation, headlines about carcinogen-tainted blood pressure medicine, ...

Read more →

Canada's decision to make public more clinical trial data puts pressure on FDA

11 October 2019 - Last March, Canada's department of health changed the way it handles the huge amount of data ...

Read more →

FDA informs patients, providers and manufacturers about potential cybersecurity vulnerabilities for connected medical devices and health care networks that use certain communication software

1 October 2019 - Today, the U.S. FDA is informing patients, health care professionals, IT staff in health care facilities and ...

Read more →

Paper by European regulators foresees "continuing reduction in clinical data requirements" for biosimilars

24 September 2019 - This month, Elena Wolff-Holz, chair of the EMA’s Biosimilar Medicinal Products Working Party, together with co-authors from ...

Read more →

Susan G. Komen Big Data for Breast Cancer Initiative: how patient advocacy organisations can facilitate using big data to improve patient outcomes

12 September 2019 - Integrating different types of data, including electronic health records, imaging data, administrative and claims databases, large data ...

Read more →

The startup that manipulated data to get a miracle drug to market

14 September 2019 - AveXis had a revolutionary gene therapy for babies with a deadly disease, and sold to Novartis for ...

Read more →

Reeling from scandal, Novartis vows to voluntarily release info on manipulated data in the future

9 September 2019 - Seeking to appease angry regulators, Novartis committed to notifying the FDA within five business days of ...

Read more →

FDA focuses on Novartis delay in reporting drug-test data manipulation

22 August 2019 - Regulators zeroing in on the company’s two-month delay in launching a formal inquiry. ...

Read more →

FDA on Novartis data manipulation controversy: ‘we happened to be lucky’

21 August 2019 - Since the FDA blasted Novartis earlier this month over data manipulation, one of the major questions ...

Read more →

Novartis delayed reveal of bad data for $2.1 million gene therapy. Now patients and pharma suffer.

20 August 2019 - Novartis CEO had a rocky start to his tenure.  ...

Read more →

Ousted Novartis scientist ‘categorically denies’ wrongdoing in data manipulation scandal

20 August 2019 - The scientist, Brian Kaspar, “is a respected member of the scientific community with an impeccable record,” his ...

Read more →